FI832825A0 - Jaesthybridvektorer och deras anvaendning foer framstaellning av polypeptider - Google Patents
Jaesthybridvektorer och deras anvaendning foer framstaellning av polypeptiderInfo
- Publication number
- FI832825A0 FI832825A0 FI832825A FI832825A FI832825A0 FI 832825 A0 FI832825 A0 FI 832825A0 FI 832825 A FI832825 A FI 832825A FI 832825 A FI832825 A FI 832825A FI 832825 A0 FI832825 A0 FI 832825A0
- Authority
- FI
- Finland
- Prior art keywords
- yeast
- promoter
- polypeptides
- vectors
- wheelset
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Communicable Diseases (AREA)
- Toxicology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8222883 | 1982-08-09 | ||
GB8222883 | 1982-08-09 | ||
GB8237026 | 1982-12-31 | ||
GB8237026 | 1982-12-31 | ||
GB838315145A GB8315145D0 (en) | 1982-08-09 | 1983-06-02 | Yeast hybrid vectors |
GB8315145 | 1983-06-02 |
Publications (4)
Publication Number | Publication Date |
---|---|
FI832825A0 true FI832825A0 (fi) | 1983-08-05 |
FI832825A FI832825A (fi) | 1984-02-10 |
FI80720B FI80720B (fi) | 1990-03-30 |
FI80720C FI80720C (fi) | 1990-07-10 |
Family
ID=27261693
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI832825A FI80720C (fi) | 1982-08-09 | 1983-08-05 | Saccharmyces cerevisiae-hybridvektorer och deras anvaendning foer framstaellning av plypeptider. |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0100561B1 (fi) |
JP (2) | JPH0653073B2 (fi) |
AT (1) | ATE43636T1 (fi) |
AU (1) | AU566348B2 (fi) |
CA (1) | CA1341381C (fi) |
CY (1) | CY1451A (fi) |
DD (1) | DD218118A5 (fi) |
DE (1) | DE3379960D1 (fi) |
DK (1) | DK174905B1 (fi) |
ES (3) | ES8505724A1 (fi) |
FI (1) | FI80720C (fi) |
GB (1) | GB2125047B (fi) |
GR (1) | GR78924B (fi) |
HK (1) | HK90688A (fi) |
HU (1) | HU204095B (fi) |
IE (1) | IE55598B1 (fi) |
NO (1) | NO172548C (fi) |
NZ (1) | NZ205178A (fi) |
PH (1) | PH25617A (fi) |
PT (1) | PT77167B (fi) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2125047B (en) * | 1982-08-09 | 1986-02-19 | Ciba Geigy Ag | Yeast hybrid vectors and their use for the production of polypeptides |
JPS5931799A (ja) * | 1982-08-16 | 1984-02-20 | Science & Tech Agency | B型肝炎ウイルス遺伝子を組込んだ組換えプラスミド |
EP0103201B1 (en) * | 1982-08-16 | 1990-05-30 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Shuttle vector |
JPS5936699A (ja) * | 1982-08-20 | 1984-02-28 | Chemo Sero Therapeut Res Inst | シヤトルベクタ− |
AU584580B2 (en) * | 1982-09-08 | 1989-06-01 | Smith Kline - Rit | Hepatitis B virus vaccine |
JPS5974988A (ja) * | 1982-10-20 | 1984-04-27 | Suntory Ltd | 酵母の誘導発現型プラスミドベクタ−およびその利用方法 |
ZA843275B (en) * | 1983-05-05 | 1984-12-24 | Hoffmann La Roche | Novel vectors for interferon expression |
DD229151A5 (de) * | 1983-11-21 | 1985-10-30 | Ciba Geigy Ag | Verfahren zur herstellung von gewebeplasminogenaktivatoren |
JPS60248181A (ja) * | 1984-05-23 | 1985-12-07 | Shiseido Co Ltd | 酵母発現ベクタ− |
US5723292A (en) * | 1984-05-25 | 1998-03-03 | Zymogenetics, Inc. | Stable DNA constructs |
AU600885B2 (en) * | 1984-05-25 | 1990-08-30 | Zymogenetics Inc. | Stable DNA constructs |
GB8415186D0 (en) * | 1984-06-14 | 1984-07-18 | Ciba Geigy Ag | Polypeptides |
JPS61502655A (ja) * | 1984-07-09 | 1986-11-20 | インテグレ−テッド・ジェネティックス・インコ−ポレ−テッド | 酵母クロ−ニングビヒクル |
JPS61502795A (ja) * | 1984-07-09 | 1986-12-04 | レモント,ジェフリ−・エフ | 酵母クロ−ニング ビ−クル |
WO1986000923A1 (en) * | 1984-07-31 | 1986-02-13 | Integrated Genetics, Inc. | Yeast cloning vehicles |
JPS61103895A (ja) * | 1984-10-26 | 1986-05-22 | Green Cross Corp:The | HBsAgの精製方法 |
DE3587307T2 (de) * | 1984-12-06 | 1993-09-02 | Fina Research | Transformierte hefen die lysozym produzieren, fuer diese transformation zu verwendende plasmide und deren verwendung. |
EP0194006B1 (en) * | 1985-02-01 | 1992-04-29 | Imperial Chemical Industries Plc | Analogous interferon polypeptides, process for their preparation and pharmaceutical compositions containing them |
GB8521496D0 (en) * | 1985-08-29 | 1985-10-02 | Ciba Geigy Ag | Repressible yeast promoters |
JPS62151183A (ja) * | 1985-09-18 | 1987-07-06 | Green Cross Corp:The | 酵母プロモ−タ−及び異種蛋白質の製造方法 |
DE3675724D1 (de) * | 1985-09-18 | 1991-01-03 | Green Cross Corp | Hefe-promotor und verfahren zur herstellung von heterologen proteinen. |
GB8530631D0 (en) | 1985-12-12 | 1986-01-22 | Ciba Geigy Ag | Thrombin inhibitors |
GB2188049B (en) * | 1986-03-15 | 1990-09-05 | Ciba Geigy Ag | Insecticidal proteinaceous substance |
EP0240224A3 (en) * | 1986-03-31 | 1989-02-01 | Interferon Sciences, Inc. | An alpha interferon analogue |
US4857467A (en) * | 1986-07-23 | 1989-08-15 | Phillips Petroleum Company | Carbon and energy source markers for transformation of strains of the genes Pichia |
EP0263072B1 (en) | 1986-10-03 | 1994-03-23 | Ciba-Geigy Ag | Novel lymphokine related peptides |
US5013652A (en) * | 1986-10-14 | 1991-05-07 | Genex Corporation | Composite yeast vectors |
ES2063161T3 (es) * | 1988-03-07 | 1995-01-01 | Ciba Geigy Ag | Proteinas modificadas. |
US5180667A (en) * | 1988-03-07 | 1993-01-19 | Ciba-Geigy Corporation | Genes encoding eglin C mutants |
EP0394409B1 (en) | 1988-09-02 | 1997-06-11 | The Rockefeller University | Macrophage-derived inflammatory mediator (mip-2) |
JPH02145193A (ja) * | 1988-11-19 | 1990-06-04 | Lotte Confectionery Co Ltd | 遺伝子の組換えによる酵母でのヒト・アルファ・インターフェロンの製造方法 |
AU648214B2 (en) * | 1991-12-31 | 1994-04-14 | Lucky Limited | Recombinant gene coding for human alpha interferon and expression vector thereof, etc. |
EP0752853B1 (en) | 1993-03-10 | 2005-09-21 | Smithkline Beecham Corporation | Human brain phosphodiesterase |
US6500645B1 (en) | 1994-06-17 | 2002-12-31 | Novo Nordisk A/S | N-terminally extended proteins expressed in yeast |
WO2004024885A2 (en) | 2002-09-13 | 2004-03-25 | Cornell Research Foundation, Inc. | Using mutations to improve aspergillus phytases |
DE102005030552B4 (de) * | 2005-06-22 | 2009-05-28 | Eucodis Bioscience | Selektion von Phosphatase-Aktivität |
CN102059495A (zh) * | 2010-11-06 | 2011-05-18 | 中国长江航运集团宜昌船厂 | 一种船体框架胎模及加工方法 |
CN105821078A (zh) | 2010-12-09 | 2016-08-03 | 巴斯德研究所 | 用于获得高产量重组蛋白表达的基于mgmt的方法 |
EP2768950B1 (en) | 2011-10-20 | 2018-03-07 | University of Iowa Research Foundation | N-demethyase genes and uses thereof |
AU2012350229B2 (en) | 2011-12-09 | 2018-03-22 | Institut Pasteur | Multiplex immuno screening assay |
WO2013187957A1 (en) | 2012-06-15 | 2013-12-19 | University Of Iowa Research Foundation | Caffeine responsive promoters and regulatory genes |
WO2022049409A1 (en) | 2020-09-02 | 2022-03-10 | Sia Terragen | Express diagnosticum for sars-cov-2 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2458585A1 (fr) * | 1979-06-07 | 1981-01-02 | Pasteur Institut | Procede de production de proteines par expression des genes correspondants dans des micro-organismes et vecteurs susceptibles d'etre mis en oeuvre dans de tels procedes |
EP0046790A4 (en) * | 1980-02-25 | 1983-01-31 | Richard Axel | USE OF EUKARYOTIC PROMOTOR SEQUENCES IN THE PRODUCTION OF PROTEIN MATERIAL. |
IL63270A0 (en) * | 1980-08-05 | 1981-10-30 | Univ Leland Stanford Junior | Eukaryotic autonomously replicating segment |
IL63035A (en) * | 1980-09-09 | 1985-05-31 | Univ California | Dnas capable of replication and stable mitotic maintenance in a host eukaryote,their preparation and eukaryotic cells comprising them |
NZ199722A (en) * | 1981-02-25 | 1985-12-13 | Genentech Inc | Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain |
AU560472B2 (en) * | 1981-08-25 | 1987-04-09 | Celltech Limited | Yeast expression vectors |
NZ201705A (en) * | 1981-08-31 | 1986-03-14 | Genentech Inc | Recombinant dna method for production of hepatitis b surface antigen in yeast |
GB2125047B (en) * | 1982-08-09 | 1986-02-19 | Ciba Geigy Ag | Yeast hybrid vectors and their use for the production of polypeptides |
JPS5931799A (ja) * | 1982-08-16 | 1984-02-20 | Science & Tech Agency | B型肝炎ウイルス遺伝子を組込んだ組換えプラスミド |
-
1983
- 1983-07-14 GB GB08319099A patent/GB2125047B/en not_active Expired
- 1983-08-05 FI FI832825A patent/FI80720C/fi not_active IP Right Cessation
- 1983-08-08 DE DE8383107804T patent/DE3379960D1/de not_active Expired
- 1983-08-08 ES ES524816A patent/ES8505724A1/es not_active Expired
- 1983-08-08 EP EP83107804A patent/EP0100561B1/en not_active Expired
- 1983-08-08 HU HU832799A patent/HU204095B/hu unknown
- 1983-08-08 IE IE1860/83A patent/IE55598B1/en not_active IP Right Cessation
- 1983-08-08 CA CA000617149A patent/CA1341381C/en not_active Expired - Fee Related
- 1983-08-08 AU AU17682/83A patent/AU566348B2/en not_active Expired
- 1983-08-08 AT AT83107804T patent/ATE43636T1/de not_active IP Right Cessation
- 1983-08-08 NO NO832848A patent/NO172548C/no not_active IP Right Cessation
- 1983-08-08 DK DK198303614A patent/DK174905B1/da not_active IP Right Cessation
- 1983-08-08 GR GR72168A patent/GR78924B/el unknown
- 1983-08-08 NZ NZ205178A patent/NZ205178A/en unknown
- 1983-08-08 PT PT77167A patent/PT77167B/pt unknown
- 1983-08-09 JP JP58144542A patent/JPH0653073B2/ja not_active Expired - Lifetime
- 1983-08-09 DD DD83253824A patent/DD218118A5/de not_active IP Right Cessation
- 1983-08-09 PH PH29374A patent/PH25617A/en unknown
-
1985
- 1985-03-01 ES ES540880A patent/ES8607391A1/es not_active Expired
- 1985-03-01 ES ES540881A patent/ES8607026A1/es not_active Expired
-
1988
- 1988-11-10 HK HK906/88A patent/HK90688A/xx not_active IP Right Cessation
-
1989
- 1989-03-10 CY CY1451A patent/CY1451A/xx unknown
-
1990
- 1990-12-28 JP JP2419332A patent/JPH0813277B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI832825A0 (fi) | Jaesthybridvektorer och deras anvaendning foer framstaellning av polypeptider | |
DE3586189D1 (de) | Menge und verfahren zur herstellung rekombinierter erzeugnisse in grosser ausbeute. | |
HUT43630A (en) | Mammalian interleukine-4 and process for producing it | |
CZ160883A3 (en) | Process of obtaining protein being heterologous for yeast organism as an expression product, treatment an secretion of yeast | |
YU45128B (en) | Process for producing functional human urochinase proteins | |
IL88223A0 (en) | Polypeptides,process,nucleotide sequences,expression vectors and host organisms for their production and pharmaceutical compositions comprising them | |
DE3177106D1 (en) | Hybrid human leukocyte interferons, process for their microbial production, intermediates therefor and compositions containing them | |
IL85878A (en) | Dna coding for anticoagulant proteins (vac), vac proteins encoded thereby, processes for preparing them, pharmaceutical compositions containing the proteins, monoclunal antibodies against such proteins and hybrid cell lines which secrete these antibodies | |
NZ211827A (en) | Production of polypeptides having interferon activity, polypeptide compositions and dna | |
GR3015881T3 (en) | Production of Kallikrein. | |
GR3020993T3 (en) | Novel process for the production of unfused protein in E. coli | |
HUT50195A (en) | New peptites hindering the activity of immune system and medical compositions containing them and process for production of these peptides and compositions | |
EP0072541A3 (en) | Human leukocyte interferons, process for their microbial production, intermediates therefor and compositions containing them | |
DE3853590D1 (de) | Rinder granulocyt-makrophagenkolonie stimulierender faktor. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Transfer of assignment of patent |
Owner name: NOVARTIS AG |
|
MA | Patent expired |
Owner name: NOVARTIS AG |